Department of Urology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Department of Urology, The Central Hospital of Xiaogan, Xiaogan, China.
World J Urol. 2024 Oct 9;42(1):570. doi: 10.1007/s00345-024-05263-z.
One key focus of partial nephrectomy is preserving renal function. Segmental renal artery occlusion with microdissection at the renal hilum confines ischemia, effectively reducing warm ischemic injury. Ultrasound-Guided Renal Artery Balloon Catheter Occluded Hybrid Partial Nephrectomy (UBo-HPN) can achieve branch occlusion without the need for dissecting the renal hilum.
To investigate the feasibility and safety of UBo-HPN of branch renal artery occlusion in the treatment of localized renal tumors.
A prospective single-arm analysis involving 20 patients with renal localized tumors underwent robot assisted UBo-HPN with branch renal artery occlusion from August 2021 to July 2023, with an average follow-up of 12 months.
All patient was successfully operated on without conversion to conventional arterial clamping or radical nephrectomy. One case (5%) of minor complication occurred in the whole cohort, which was bruising around the puncture site. The mean total operative time was 95.8 min, with a mean operative time of 21.25 min for vascular intervention. The mean warm ischemia time was 20.35 min, and the median estimated blood loss was 50 ml. The median eGFR preservation percentage at postoperative 48 h, 30 days, and the latest follow-up were 87.52%, 91.47%, and 92.2%, respectively. After a median follow-up of 10.2 (2.3-19.2) months, no patients had radiological tumor recurrence or died from tumor-related causes.
UBo-HPN with renal artery branch occlusion emerges as an efficient alternative to partial nephrectomy (PN), which achieved branch artery occlusion without dissecting the renal hilum. Long-term follow-up is expected for functional outcomes.
部分肾切除术的一个关键焦点是保留肾功能。在肾门处进行微解剖的节段性肾动脉闭塞限制了缺血,有效地减少了热缺血损伤。超声引导下肾动脉球囊导管闭塞杂交部分肾切除术(UBo-HPN)可以实现分支闭塞,而无需解剖肾门。
探讨 UBo-HPN 分支肾动脉闭塞治疗局限性肾肿瘤的可行性和安全性。
一项前瞻性单臂分析纳入了 20 例接受机器人辅助 UBo-HPN 分支肾动脉闭塞治疗的局限性肾肿瘤患者,自 2021 年 8 月至 2023 年 7 月,平均随访 12 个月。
所有患者均成功完成手术,无一例转为常规动脉夹闭或根治性肾切除术。整个队列中有 1 例(5%)发生轻微并发症,为穿刺部位周围淤青。总手术时间平均为 95.8 分钟,血管介入手术平均时间为 21.25 分钟。平均热缺血时间为 20.35 分钟,中位估计失血量为 50ml。术后 48 小时、30 天和最新随访时的中位 eGFR 保留率分别为 87.52%、91.47%和 92.2%。中位随访 10.2(2.3-19.2)个月后,无患者出现影像学肿瘤复发或因肿瘤相关原因死亡。
UBo-HPN 联合肾动脉分支闭塞术是一种有效的部分肾切除术(PN)替代方法,可实现分支动脉闭塞而无需解剖肾门。预计需要进行长期随访以评估其功能结果。